descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1991 English Publisher:Cambridge University Press (CUP)Journal:International Journal of Technology Assessment in Health Care, volume 7, pages 21-25 (issn: 0266-4623, eissn: 1471-6348,

Authors: Mikko Hallman; Maija Pohjavuori; Kristiina Bry; T. Allen Merritt;

doi: 10.1017/s0266462300012459

pmid: 2037433

Neonatal Surfactant Deficiency and Surfactant Replacement Therapy

- Summary
- Subjects
- Metrics

Abstract

For the past 25 years, attempts have been made to treat respiratory distress syndrome (RDS) by administration of surfactant into the airways. This practice is not yet an accepted form of therapy. Lack of generally available surfactant during the present era of prospective studies will hopefully decrease the therapeutic misuse of this novel medicine.

Related Organizations

University of California, San Diego
United States
University of Helsinki
Finland
University of California, San Diego
United States

Keywords

Respiratory Distress Syndrome, Newborn, Surface-Active Agents, Age Factors, Infant, Newborn, Animals, Humans, Pulmonary Surfactants

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average